- Exchange: Dublin
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Snapshot for Elan Corp PLC (ELN)
| Open: | 10.3500 | Day's Range: | 10.3500 - 10.6000 | Volume: | 11,132 |
|---|---|---|---|---|---|
| Previous Close: | 10.1100 | 52wk Range: | 6.8290 - 11.7840 | 1-Yr Rtn: | -5.68% |
Key Statistics for ELN
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. ISEQ | - |
| Earnings Per Share (USD) (ttm) | -0.0855 |
| Est. EPS (USD) (12/2013) | -0.1430 |
| Est. PEG Ratio | - |
| Market Cap (M EUR) | 5,391.65 |
| Shares Outstanding (M) | 511.52 |
| 30 Day Average Volume | 340,296 |
| Price/Book (mrq) | 12.0585 |
| Price/Sale (ttm) | 13.6911 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 07/25/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for ELN
Company Profile & Key Executives for ELN
Elan Corporation plc is a specialty pharmaceutical company. The Group's drug delivery technologies are designed to aid and control the absorption and utilization of active pharmaceutical compounds. Elan's Pharmaceutical division focuses on the discovery, development and commercialization of products in the areas of acute care, pain management, infectious diseases and neurology.
| G Kelly MartinChief Executive Officer | Hans Peter HaslerChief Operating Officer |
| Fabiana Lacerca-AllenChief Compliance Officer | Guriq BasiChief Science & Tech Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
ELN News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page